EUVIMEDEUVIMED entdecken
FallberichtLeserbrief

A novel variant with a severe phenotype in a patient with CARD14 -associated papulosquamous eruption successfully treated with ixekizumab

Xiaoliang Ouyang, Deng Zhang, Xiuping Wang, Liang Wu, Zhen Xiao, Yunxia Zhu, Simin Yu, Chunming Li iD

Clinical and Experimental Dermatology · 2024

DOI: 10.1093/ced/llae019 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical and Experimental Dermatology, 2024. Verfasst von Xiaoliang Ouyang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Plastic Surgery. Hauptthemen laut MEDLINE: CARD Signaling Adaptor Proteins, Antibodies, Monoclonal, Humanized, Guanylate Cyclase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Regional Science Foundation, Natural Science Foundation of Jiangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CARD14-associated papulosquamous eruption (CAPE) is an autosomal dominant disorder characterized by early onset of symptoms, prominent facial involvement, clinical manifestations resembling both psoriasis and pityriasis rubra pilaris (PRP), family history of psoriasis or PRP and limited response to conventional topical and systemic therapies for psoriasis or PRP. Here, we describe the clinical features of a patient with CAPE and a novel mutation of CARD14.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CARD Signaling Adaptor ProteinsAntibodies, Monoclonal, HumanizedGuanylate CyclaseHumansMembrane ProteinsPhenotypeSkin Diseases, PapulosquamousDermatologic AgentsMaleFemale

Substanzen

CARD Signaling Adaptor ProteinsAntibodies, Monoclonal, HumanizedGuanylate CyclaseMembrane ProteinsDermatologic AgentsixekizumabCARD14 protein, human

Autor:innen und Institutionen

  • Departments of Plastic Surgery.
  • Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, People's Republic of China.
  • Department of Dermatology, Taiyuan Central Hospital, Taiyuan, Shanxi, People's Republic of China.

ORCID-Profile: Chunming Li

Förderung

  • National Natural Science Foundation of China
  • Regional Science Foundation
  • Natural Science Foundation of Jiangxi Province

Zitieren

APA

Ouyang, X., Zhang, D., Wang, X., Wu, L., Xiao, Z., Zhu, Y., Yu, S., & Li, C. (2024). A novel variant with a severe phenotype in a patient with CARD14 -associated papulosquamous eruption successfully treated with ixekizumab. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae019

Vancouver

Ouyang X, Zhang D, Wang X, Wu L, Xiao Z, Zhu Y, et al. A novel variant with a severe phenotype in a patient with CARD14 -associated papulosquamous eruption successfully treated with ixekizumab. Clinical and Experimental Dermatology. 2024. doi:10.1093/ced/llae019

BibTeX
@article{Ouyang2024,
  author = {Ouyang, Xiaoliang and Zhang, Deng and Wang, Xiuping and Wu, Liang and Xiao, Zhen and Zhu, Yunxia and Yu, Simin and Li, Chunming},
  title = {A novel variant with a severe phenotype in a patient with CARD14 -associated papulosquamous eruption successfully treated with ixekizumab},
  journal = {Clinical and Experimental Dermatology},
  year = {2024},
  doi = {10.1093/ced/llae019}
}
Kostenlos starten →